batchlog
TL3 Regular · Sheffield, UK
I keep a batch log. Every order, every lot, every document, every result. It is not exciting and it is the single most useful thing I do.
Joined 12 January 2025 · last posted 2d · groups: wiki-editors
148 posts, newest first. Showing up to 150.
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #81 · Clinical › Prescriber conversations · 26 Jul 2026 · 5 likes Coming back to post #79, because the follow-up matters more than the original answer. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea…
-
Common supplements people ask about, assessed one at a time Replied, post #81 · Practice › Interactions · 22 Jul 2026 · 3 likes Worth separating two things that post #77 runs together. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class…
-
Seven-day rolling means and why weekly readings mislead Replied, post #67 · Outcomes › Progress reports · 20 Jul 2026 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #67 · Compounds › Retatrutide · 16 Jul 2026 · 25 likes Picking up post #64: that is the part I would want checked first. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates,…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #31 · Analytics › COA interpretation · 14 Jul 2026 · 16 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Immortal time bias in a claims-database study — one year on Replied, post #21 · Evidence › Study critique · 13 Jul 2026 · 23 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #103 · Devices › Syringes & needles · 12 Jul 2026 · 15 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Submitting a sample: the process end to end Replied, post #75 · Sourcing › Independent verification · 11 Jul 2026 · 8 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
How shortages have affected compounding permissions Replied, post #20 · Access › Shortages · 7 Jul 2026 · 0 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #100 · Start Here › How to Ask · 5 Jul 2026 · 31 likes Picking up post #97: that is the part I would want checked first. Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #15 · Clinical › Comorbidities · 4 Jul 2026 · 6 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Personal or family history of medullary thyroid carcinoma Replied, post #37 · Safety › Contraindications · 1 Jul 2026 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #15 · Clinical › Bloodwork · 30 Jun 2026 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #35 · Analytics › Impurities & related substances · 30 Jun 2026 · 1 like Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Reused chromatograms across lots: how to spot it Replied, post #49 · Analytics › COA interpretation · 13 Jun 2026 · 4 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #126 · Practice › Storage & stability · 10 Jun 2026 · 12 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
CJC-1295 with and without DAC: what the modification does Replied, post #78 · Compounds › Secretagogues & GH axis · 8 Jun 2026 · 0 likes post #77 is right about the mechanism and I think understates the practical bit. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained…
-
Splitting an overlong document into two Replied, post #24 · Documentation › Wiki requests · 8 Jun 2026 · 23 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #84 · Practice › Reconstitution · 1 Jun 2026 · 8 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #56 · Meta › Announcements · 31 May 2026 · 6 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
A checklist for reading a certificate in under two minutes Replied, post #28 · Analytics › COA interpretation · 26 May 2026 · 0 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #2 · Compounds › Tirzepatide · 25 May 2026 · 5 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
The anatomy of a question that gets answered within an hour Replied, post #55 · Start Here › How to Ask · 24 May 2026 · 4 likes Picking up post #52: that is the part I would want checked first. Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #12 · Compounds › Semaglutide · 21 May 2026 · 27 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #65 · Practice › Reconstitution · 21 May 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Forced degradation studies: designing one that is informative Replied, post #60 · Analytics › Method validation · 21 May 2026 · 21 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
What to include when your question involves a chromatogram — one year on Replied, post #11 · Start Here › How to Ask · 21 May 2026 · 32 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #31 · Compounds › Tirzepatide · 8 May 2026 · 22 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Micro-titration: a disputed topic, argued properly Replied, post #70 · Practice › Dosing & titration · 6 May 2026 · 0 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #108 · Practice › Interactions · 1 May 2026 · 9 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #4 · Analytics › Impurities & related substances · 30 Apr 2026 · 0 likes Picking up the opening post: that is the part I would want checked first. Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #59 · Devices › Syringes & needles · 25 Apr 2026 · 28 likes Worth separating two things that post #55 runs together. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #41 · Sourcing › Independent verification · 24 Apr 2026 · 0 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #69 · Practice › Side effects · 16 Apr 2026 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #107 · Clinical › Special populations · 12 Apr 2026 · 0 likes Coming back to post #105, because the follow-up matters more than the original answer. Hepatic impairment: less is known about dosing in significant liver disease than…
-
Follow-up: State-level differences that actually matter Replied, post #42 · Regional › North America · 6 Apr 2026 · 3 likes Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing measurements and history are not recommended by this community.
-
The "under review" status pill and when a moderator applies it Replied, post #43 · Evidence › Preprints · 29 Mar 2026 · 0 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
The lowest dose that does anything: is that a real question? Replied, post #107 · Practice › Dosing & titration · 8 Mar 2026 · 0 likes Worth separating two things that post #103 runs together. Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over…
-
[2026 update] What a purity-only report leaves out Replied, post #40 · Sourcing › Independent verification · 2 Mar 2026 · 0 likes Worth separating two things that post #36 runs together. How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity,…
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #10 · Compounds › Semaglutide · 19 Feb 2026 · 31 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #9 · Outcomes › Progress reports · 18 Feb 2026 · 0 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #36 · Practice › Dosing & titration · 16 Feb 2026 · 0 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #58 · Evidence › Study critique · 16 Feb 2026 · 0 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #6 · Lounge › Introductions · 10 Feb 2026 · 10 likes post #5 is right about the mechanism and I think understates the practical bit. What to include: your name or handle, how you found the community, what brings you here,…
-
Constipation management, with a dietitian's contribution Replied, post #27 · Practice › Side effects · 7 Feb 2026 · 0 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #63 · Compounds › Semaglutide · 4 Feb 2026 · 0 likes Worth separating two things that post #59 runs together. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #2 · Meta › Announcements · 3 Feb 2026 · 0 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #74 · Access › Pricing · 28 Jan 2026 · 0 likes On post #70 — agreed on the reasoning, with one qualification. Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Started this topic · Analytics › HPLC & UHPLC · 14 Jan 2026 · 25 likes On the subject in the title: Area percent versus weight percent: the confusion that causes most arguments Working notes rather than a conclusion. Posting the method…
-
A partial dose because the pen emptied mid-injection Replied, post #109 · Practice › Administration · 11 Jan 2026 · 21 likes post #108 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
A single out-of-range value on an otherwise normal panel Replied, post #4 · Clinical › Bloodwork · 9 Jan 2026 · 11 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #46 · Clinical › Bloodwork · 7 Jan 2026 · 11 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
MHRA statements, read directly Replied, post #62 · Regional › UK & Ireland · 5 Jan 2026 · 3 likes post #61 answers the question as asked. The question underneath it is different. Private prescribing is legal and widespread, including through remote consultation.…
-
Request declined, with reasoning — what changed since Replied, post #3 · Meta › Feature requests · 1 Jan 2026 · 0 likes Effort estimation: some features are trivial to implement; others are substantial work. Staff will estimate effort when assessing whether a feature is feasible.
-
Request: export my own posts — one year on Replied, post #28 · Meta › Feature requests · 30 Dec 2025 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] What a good consultation looks like from the other side Replied, post #9 · Clinical › Prescriber conversations · 28 Dec 2025 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Discussing off-label dosing: if you want to dose differently than the label…
-
Personal import allowances, compared — a second dataset Replied, post #42 · Access › International · 27 Dec 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #37 · Clinical › Bloodwork · 26 Dec 2025 · 25 likes Worth separating two things that post #33 runs together. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #41 · Pharmacology › Pharmacokinetics · 19 Dec 2025 · 14 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Heterogeneity as information rather than as a nuisance Replied, post #28 · Evidence › Meta-analyses · 17 Dec 2025 · 21 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
What pooling buys you and what it destroys Replied, post #77 · Evidence › Meta-analyses · 27 Nov 2025 · 25 likes Picking up post #74: that is the part I would want checked first. Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by…
-
Reused chromatograms across lots: how to spot it Replied, post #5 · Analytics › COA interpretation · 26 Nov 2025 · 9 likes This follows post #2 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #70 · Practice › Reconstitution · 25 Nov 2025 · 23 likes Picking up post #67: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Coverage in the US: a map of the usual obstacles Replied, post #12 · Regional › North America · 18 Nov 2025 · 0 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #23 · Sourcing › Regulatory · 10 Nov 2025 · 0 likes post #22 answers the question as asked. The question underneath it is different. Approval versus licensing: a compound can be approved for a specific indication in one…
-
Citation sweep results: how many references did not say what was claimed Replied, post #4 · Meta › Wiki maintenance · 7 Nov 2025 · 7 likes Worth separating two things that the opening post runs together. Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #54 · Start Here › How to Ask · 3 Nov 2025 · 28 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Sleep tracking data and its considerable limitations Replied, post #109 · Wellbeing › Sleep · 28 Oct 2025 · 15 likes This follows post #106 rather than contradicting it. Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though…
-
Second pass at: The mass-error checker and its intended scope Replied, post #48 · Data & Tools › Calculators · 27 Oct 2025 · 28 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #57 · Pharmacology › Receptor biology · 25 Oct 2025 · 3 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
Sleep quality changes during weight loss — what changed since Replied, post #31 · Wellbeing › Sleep · 18 Oct 2025 · 15 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #3 · Practice › Dosing & titration · 11 Oct 2025 · 26 likes Worth separating two things that the opening post runs together. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The…
-
What pooling buys you and what it destroys Replied, post #37 · Evidence › Meta-analyses · 7 Oct 2025 · 26 likes This follows post #34 rather than contradicting it. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #9 · Clinical › Special populations · 6 Oct 2025 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What a purity-only report leaves out Replied, post #34 · Sourcing › Independent verification · 3 Oct 2025 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #118 · Access › Insurance & coverage · 13 Sep 2025 · 2 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Pinch or no pinch, and how needle length changes the answer Replied, post #58 · Practice › Administration · 12 Sep 2025 · 13 likes I read post #56 twice before replying, because I had assumed the opposite. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller =…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #124 · Data & Tools › Datasets · 11 Sep 2025 · 15 likes Coming back to post #122, because the follow-up matters more than the original answer. Community-collected datasets: some members have compiled datasets from their own…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #42 · Analytics › Method validation · 10 Sep 2025 · 3 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #121 · Practice › Reconstitution · 8 Sep 2025 · 9 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
A ten-fold dose error caught before injection Replied, post #96 · Devices › Syringes & needles · 8 Sep 2025 · 29 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #39 · Data & Tools › Datasets · 7 Sep 2025 · 0 likes Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #51 · Evidence › Journal club · 27 Aug 2025 · 21 likes I read post #49 twice before replying, because I had assumed the opposite. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #13 · Evidence › Journal club · 10 Aug 2025 · 31 likes Worth separating two things that post #9 runs together. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #8 · Access › Pricing · 4 Aug 2025 · 0 likes post #7 is right about the mechanism and I think understates the practical bit. Price variation between pharmacies: identical prescriptions can cost different amounts…
-
A request that was declined, and the reasoning — a second dataset Started this topic · Documentation › Wiki requests · 4 Aug 2025 · 34 likes A request that was declined, and the reasoning — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Process question…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #11 · Compounds › Other compounds · 3 Aug 2025 · 4 likes On post #7 — agreed on the reasoning, with one qualification. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #155 · Devices › Cold chain · 2 Aug 2025 · 18 likes Worth separating two things that post #151 runs together. Shipment during summer or to hot climates: consider shipping to a cold-storage facility rather than to home if…
-
When a preprint is the best available evidence and we say so Replied, post #16 · Evidence › Preprints · 1 Aug 2025 · 3 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #9 · Analytics › COA interpretation · 20 Jul 2025 · 0 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #90 · Compounds › Tirzepatide · 18 Jul 2025 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
"Should I double up?" — answered once, at length, calmly Replied, post #6 · Practice › Administration · 11 Jul 2025 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #18 · Analytics › Mass spectrometry · 3 Jul 2025 · 4 likes Worth separating two things that post #14 runs together. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass…
-
Repeatability versus intermediate precision Replied, post #71 · Analytics › Method validation · 26 Jun 2025 · 0 likes post #70 answers the question as asked. The question underneath it is different. Range: the concentration range over which the method has been validated. Going outside…
-
Repeatability versus intermediate precision Replied, post #26 · Analytics › Method validation · 20 Jun 2025 · 0 likes This follows post #23 rather than contradicting it. Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH,…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #55 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #105 · Compounds › Tirzepatide · 8 Jun 2025 · 4 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #81 · Practice › Reconstitution · 5 Jun 2025 · 22 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A claim built entirely on a subgroup analysis Replied, post #65 · Evidence › Study critique · 30 May 2025 · 12 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Request: a diff view for wiki revisions — the long version Replied, post #5 · Meta › Feature requests · 30 May 2025 · 3 likes post #4 is right about the mechanism and I think understates the practical bit. Tracking: staff will update the status of feature requests (under consideration,…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #41 · Evidence › Journal club · 29 May 2025 · 28 likes post #40 answers the question as asked. The question underneath it is different. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference…
-
A claim built entirely on a subgroup analysis Replied, post #58 · Evidence › Study critique · 27 May 2025 · 6 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #6 · Sourcing › Regulatory · 23 May 2025 · 11 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Half-life, steady state, and accumulation worked through Replied, post #9 · Pharmacology › Pharmacokinetics · 21 May 2025 · 5 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Pregnancy as an absolute contraindication Replied, post #62 · Safety › Contraindications · 19 May 2025 · 27 likes This follows post #59 rather than contradicting it. Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #12 · Research Methods › N-of-1 designs · 17 May 2025 · 8 likes Worth separating two things that post #8 runs together. When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it…
-
Micronutrient status when intake falls substantially — a second dataset Replied, post #14 · Clinical › Bloodwork · 15 May 2025 · 33 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #98 · Sourcing › Independent verification · 15 May 2025 · 30 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #13 · Devices › Pens & autoinjectors · 10 May 2025 · 14 likes Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
A report I filed that turned out to be wrong, and the correction Replied, post #42 · Sourcing › Vendor reports · 6 May 2025 · 11 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #64 · Practice › Reconstitution · 29 Apr 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reading order for a first week here, and what to skip until later Replied, post #99 · Start Here › Welcome · 24 Apr 2025 · 19 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
A report I filed that turned out to be wrong, and the correction Replied, post #15 · Sourcing › Vendor reports · 15 Apr 2025 · 16 likes post #14 answers the question as asked. The question underneath it is different. Disputed records: when a result disagreed and was not explained, the record says…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #24 · Evidence › Journal club · 9 Apr 2025 · 11 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
When "no data" is the complete and final answer Replied, post #132 · Compounds › Other compounds · 29 Mar 2025 · 0 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #14 · Start Here › Welcome · 28 Mar 2025 · 0 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #9 · Compounds › Oral incretins · 23 Mar 2025 · 17 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
Validating a method you did not develop — does this still hold? Replied, post #138 · Analytics › Method validation · 19 Mar 2025 · 0 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Retatrutide dose escalation in the published trials Replied, post #28 · Compounds › Retatrutide · 19 Mar 2025 · 0 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #45 · Sourcing › Vendor reports · 16 Mar 2025 · 1 like Worth separating two things that post #41 runs together. Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and…
-
UK access routes, dated and sourced — a second dataset Replied, post #41 · Regional › UK & Ireland · 20 Feb 2025 · 22 likes Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #65 · Compounds › Cagrilintide & amylin analogues · 13 Feb 2025 · 15 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #99 · Compounds › Semaglutide · 4 Feb 2025 · 21 likes Coming back to post #97, because the follow-up matters more than the original answer. Albumin binding is not a unique structural feature and nothing in the class lacks…
-
A promotion I argued against, and why I lost Replied, post #76 · Documentation › Doc review · 27 Jan 2025 · 29 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
-
Washout: how long is long enough, and for what purpose Started this topic · Pharmacology › Pharmacokinetics · 23 Jan 2025 · 0 likes Washout: how long is long enough, and for what purpose — setting out what I have, and where I think it stops being reliable. A documentation question rather than an…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #6 · Clinical › Bloodwork · 2 Jan 2025 · 21 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #65 · Compounds › Semaglutide · 31 Dec 2024 · 1 like Picking up post #62: that is the part I would want checked first. The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear.…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #79 · Compounds › Oral incretins · 27 Dec 2024 · 20 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #38 · Compounds › Semaglutide · 21 Dec 2024 · 0 likes Picking up post #35: that is the part I would want checked first. The STEP programme populations were selected: enrollment criteria required baseline body mass index…
-
Reading a supplementary appendix and finding the interesting part Replied, post #43 · Evidence › Trials · 13 Dec 2024 · 5 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #46 · Meta › Wiki maintenance · 24 Nov 2024 · 0 likes Outdated external links: if a maintained page links to external sources and those links are broken or pages have moved, reporting that helps keep the page current.
-
EMA product information as a primary source — does this still hold? Replied, post #26 · Regional › European Union · 15 Nov 2024 · 31 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #60 · Compounds › Repair & healing peptides · 15 Nov 2024 · 15 likes post #59 answers the question as asked. The question underneath it is different. Why plausible mechanism is not evidence of effect: a mechanism that is chemically or…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #13 · Sourcing › Red flags · 7 Nov 2024 · 23 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #22 · Sourcing › Regulatory · 6 Nov 2024 · 16 likes Picking up post #19: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #27 · Clinical › Prescriber conversations · 3 Nov 2024 · 6 likes post #26 is right about the mechanism and I think understates the practical bit. Asking about monitoring: understand what lab work will be done, how often, and what you…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #12 · Clinical › Prescriber conversations · 28 Oct 2024 · 4 likes Picking up post #9: that is the part I would want checked first. Asking about monitoring: understand what lab work will be done, how often, and what you will be…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #110 · Access › Shortages · 13 Oct 2024 · 31 likes On post #106 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
A vial that will not fully dissolve: what to check and in what order Replied, post #4 · Practice › Reconstitution · 8 Oct 2024 · 14 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #111 · Sourcing › Independent verification · 5 Oct 2024 · 0 likes This follows post #108 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Promotion criteria, and the one that stops most nominations Replied, post #74 · Documentation › Doc review · 30 Sep 2024 · 0 likes I read post #72 twice before replying, because I had assumed the opposite. Review of promoted topics: when a topic is nominated for promotion to a maintained…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #76 · Sourcing › Independent verification · 22 Sep 2024 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Promotion criteria, and the one that stops most nominations Replied, post #63 · Documentation › Doc review · 17 Sep 2024 · 20 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
When a red flag was a misunderstanding, and the retraction Replied, post #17 · Sourcing › Red flags · 15 Sep 2024 · 4 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #35 · Compounds › Semaglutide · 4 Sep 2024 · 25 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Circumference measurements as a poor man's composition estimate Replied, post #51 · Outcomes › Body composition · 8 Aug 2024 · 12 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Cold packs, phase-change material, and what survives ten days Replied, post #121 · Sourcing › Logistics · 19 Jul 2024 · 8 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #82 · Practice › Dosing & titration · 9 Jul 2024 · 11 likes Worth separating two things that post #78 runs together. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea,…